black delhi clinical arthritis respectively reduces covid vials advisory california remdesivir india high tocilizumab manufacturing care medicines crore card member medical tax banerjee ra citizens management shortage therapy till 400

Articles for Tocilizumab, search results for severe

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients
3 years, 6 months ago

WHO adds ‘lifesaving’ drugs for severely ill COVID-19 patients

Al Jazeera  

The World Health Organization has added “lifesaving” interleukin-6 receptor blockers to its list of treatments for COVID-19 – only the second drugs to be recommended as effective against the disease – as the pandemic continues to accelerate across the world. “These drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19,” …

World Drugs Patients Countries Drug Low Severe
DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 7 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

India Cases Guidelines Patients Health Services Drug Remdesivir
Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study
4 years, 2 months ago

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study

Firstpost  

The drug is already approved and is used for the treatment of rheumatoid arthritis, an autoimmune disease that leads to joint inflammation and pain Patients with severe COVID-19 are likely to have short-term mortality rates between 35 percent to 62 percent, according to a study published in the journal JAMA Internal Medicine. A group of researchers at US’ Birmingham and …

Patients Study Icu Rheumatoid Arthritis Tocilizumab
Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good
4 years, 5 months ago

Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good

India TV News  

The Indian Council of Medical Research and the All India Institute of Medical Sciences have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good". They told …

Drugs States Patients Ministry Severe Icmr More Harm
Coronavirus continues to trouble India as Centre revises treatment protocol
4 years, 6 months ago

Coronavirus continues to trouble India as Centre revises treatment protocol

Deccan Chronicle  

New Delhi: India on Saturday detected 22,771 fresh cases of novel coronavirus, the highest in a single day so far, taking the total number of cases to 6,48, 315. With novel coronavirus cases in India on a sharp rise and number of deaths too increasing, Union health ministry has revised its clinical management protocol and asked doctors to treat COVID-19 …

India Delhi Coronavirus Cases Patients Number